Breast Neoplasms: all 12,820 studies

Page 24 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.

• Evaluating the Efficacy and Safety of Fulvestrant Plus DNA Damage Repair Inhibitors After a CDK4/6 InhibitorRecruitingNCT05536128Phase 2
• UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain MetastasesRecruitingNCT05535413Phase 1/2
• TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer PatientsRecruitingNCT05535192Not applicable
• A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast CancerRecruitingNCT05534438Phase 2
• Genomically Guided Radiation Therapy in the Management of Triple Negative Breast CancerRecruitingNCT05528133Phase 2
• Tamoxifen Prediction Study in Patients With ER+ Breast CancerRecruitingNCT05525481Phase 4
• Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast CancerRecruitingNCT05524584Phase 2
• Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid TumorRecruitingNCT05523947Phase 1/2
• Vitamin D and Calcium Supplementation in Breast CancerRecruitingNCT05523609Phase 2/3
• Cardio-Oncology Rehabilitation ExerciseRecruitingNCT05522959
• A Phase 1b/2 Trial Evaluating Safety and Efficacy of CAPecitabine in Combination With Ni-rapaRIb in HER2-negative Advanced Breast canCErNot yet recruitingNCT05519670Phase 1/2
• Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)RecruitingNCT05512364Phase 3
• Patient-Reported Outcome and Safety Between Preoperative and Postmastectomy Radiotherapy in DIEP Flap ReconstructionRecruitingNCT05512286Not applicable
• TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast CancerRecruitingNCT05507879
• Identifying Biomarkers for Chronic Pain After Breast Cancer Treatment.RecruitingNCT05507034
• Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Breast CancerNot yet recruitingNCT05505812Early Phase 1
• Cryoablation vs Lumpectomy in T1 Breast CancersRecruitingNCT05505643Not applicable
• Omission of Breast Surgery for Breast Cancer Patients With pCR on MRI and Vacuum-assisted Biopsy After NST (OPTIMIST)RecruitingNCT05505357Not applicable
• DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast CancerRecruitingNCT05504707Phase 1
• A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast CancerRecruitingNCT05504213Phase 1
• A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF AlterationsRecruitingNCT05503797Phase 2
• IMPACT Trial: Intervention to iMProve AdherenCe EquitablyRecruitingNCT05496829Not applicable
• Impact of Erector Spinae Plane Block on Chronic Postsurgical Pain in Breast Cancer PatientsRecruitingNCT05494502Not applicable
• Hypofractionated Radiotherapy in Breast Cancer Patients With Prosthetic ReconstructionRecruitingNCT05491395Not applicable
• Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and RadiationRecruitingNCT05491226Phase 2
• Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast CancerRecruitingNCT05491083Phase 1/2
• Treatment Patterns of Neratinib in HER2+ EBC in ChinaNot yet recruitingNCT05491057
• Robot-assisted vs. Open Nipple-sparing Mastectomy With Immediate Breast ReconstructionRecruitingNCT05490433Not applicable
• Low-field MRI for Breast Cancer ScreeningEnrolling by invitationNCT05486520Not applicable
• Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast CancerRecruitingNCT05485766Phase 2
• Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair LossRecruitingNCT05484973Not applicable
• Brass Mesh Bolus in Rotational Post-Mastectomy Radiation TherapyRecruitingNCT05483712Not applicable
• KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung CancerRecruitingNCT05483491Phase 1
• Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer CareRecruitingNCT05483283Not applicable
• Effect of Zoledronic Acid Treatment on Bone-related Events in Breast Cancer Patients With Bone Metastases: a Prospective, Multicenter, Real-world StudyNot yet recruitingNCT05480189
• Neoadjuvant Radiation in Locally Advanced Breast CancerRecruitingNCT05479409Phase 2
• Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast CancerRecruitingNCT05475678Phase 2
• Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After LumpectomyRecruitingNCT05472792Phase 2
• A Study of BL-B01D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid TumorsRecruitingNCT05470348Phase 1
• Exercise in Metastatic Breast Cancer: EMBodyRecruitingNCT05468034Not applicable
• Cardioprotective Effect of Acute Exercise in Breast Cancer PatientsRecruitingNCT05467111Not applicable
• Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)RecruitingNCT05465031Phase 4
• Chidamide in Combination With Abemaciclib and Endocrinotherapy（Doctor's Choice） in Breast Cancer Patients Previously Treated With PalbociclibRecruitingNCT05464173Phase 1/2
• TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph NodesRecruitingNCT05462457
• A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2-Positive/Negative Breast Cancer and Other Solid TumorsRecruitingNCT05461768Phase 1
• Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination DeficiencyNot yet recruitingNCT05461690Phase 2
• Breast Cancer Risk From Sonographic Glandular Tissue Component (or International GTC Study)RecruitingNCT05460975
• Acupuncture for Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.Not yet recruitingNCT05460819Not applicable
• First-in-human, Study of MATTISSE® Tissue Engineering Chamber in Adult Female Patients Undergoing Breast Reconstruction After Mastectomy for CancerRecruitingNCT05460780Not applicable
• Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast CancerRecruitingNCT05455619Phase 1/2
• Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer PatientsRecruitingNCT05452213Phase 4
• Postoperative Radiation of Patients With Breast Cancer in Extreme Hypofractionation.Not yet recruitingNCT05452083
• Treatment of Advanced or Metastatic Triple-negative Breast Cancer With Adoptive Therapy of PD1+ TILSRecruitingNCT05451784Phase 1/2
• Biological Matrices Versus Synthetic MeshesRecruitingNCT05449691Not applicable
• Study of Camrelizumab Plus Apatinib and Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)RecruitingNCT05447702Phase 2
• mULM to Support Breast Cancer Diagnosis and TherapyRecruitingNCT05445050Not applicable
• Gut Microbiome Components Predict Response to Neoadjuvant Therapy in HER2-positive Breast Cancer Patients : A Prospective StudyRecruitingNCT05444647
• Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among CliniciansRecruitingNCT05440929
• The Postoperative Radiotherapy in N1 Breast Cancer PatientsRecruitingNCT05440149Phase 3
• Opioid Free Versus Opioid Based Anaesthesia for Free Flap Reconstruction Surgery of the Breast: A Phase III Multicentric Randomized Controlled Study.RecruitingNCT05439005Phase 3
• A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in TanzaniaRecruitingNCT05438511
• Asian Multicenter Prospective Study in HER2 Positive Early Breast Cancer for Detecting MRD by ctDNA;HARMONY StudyRecruitingNCT05433753
• The Efficacy and Safety of Dalpiciclib Plus Endocrine Therapy in HR-positive / HER2-negative Advanced Breast Cancer Patients With Visceral CrisisNot yet recruitingNCT05431504Phase 2
• Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast CancerRecruitingNCT05430399Phase 3
• Clinical Study of Pyrotinib in Neoadjuvant Therapy of HR-positive and HER2-positive Breast CancerNot yet recruitingNCT05430347Phase 2
• Magnetic Marker Localization for Occult Breast Cancer and Target Axillary Dissection in Node-positive Breast Cancer Post-neoadjuvant ChemotherapyRecruitingNCT05427071Not applicable
• A Study to Evaluate the Efficacy and Safety of TSL-1502 Capsules in Breast Cancer Patients With Germline BRCA MutationsRecruitingNCT05420779Phase 2
• A Study for the Adjuvant Treatment of Breast CancerRecruitingNCT05420467Phase 4
• A Study for the Neoadjuvant Treatment of Breast CancerRecruitingNCT05420454Phase 4
• Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid MalignanciesRecruitingNCT05417594Phase 1/2
• Impact of Sleep Disturbance on Cognition and Quality of Life in Breast CancerRecruitingNCT05414357Not applicable
• A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast CancerRecruitingNCT05412225Phase 1
• Self-administered Acupressure to Improve Cancer-related Fatigue Among Cancer Patients Undergoing ChemotherapyRecruitingNCT05409352Not applicable
• The Effectiveness of Psychological Interventions in Psycho-neuroendocrine-immune Network in Breast Cancer SurvivorsRecruitingNCT05406531Not applicable
• Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast CancerRecruitingNCT05406232
• Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)RecruitingNCT05403177
• Aim 3, Adapting and Implementing Evidence-based Breast Cancer Follow-up in Primary CareEnrolling by invitationNCT05400941Not applicable
• Role of the Immune Environment in Response to Therapy in Breast CancerRecruitingNCT05396612
• Dosimetric Comparison of Three Radiation Techniques for Hypofractionated Whole Breast Radiotherapy in Early Breast CancerNot yet recruitingNCT05394194
• Shared Decision Making on Care Pathways and CAMs: A Pilot StudyRecruitingNCT05388734Not applicable
• Protocol for Herceptin as Adjuvant Therapy With Reduced Exposure to Chemotherapy (PHARE-C)Not yet recruitingNCT05388500Phase 3
• Kadcyla And Neratinib for Interception of HER2+ Breast Cancer With Molecular Residual DiseaseRecruitingNCT05388149Phase 2
• Cardiometabolic Screening ProgramRecruitingNCT05386719Not applicable
• Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast CancerRecruitingNCT05386108Phase 1/2
• Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AIRecruitingNCT05381038Phase 1/2
• Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize TrialRecruitingNCT05379153Phase 3
• Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer.RecruitingNCT05378204Not applicable
• A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid TumorsRecruitingNCT05377996Phase 1/2
• Stereotactic Ablative Radiotherapy for OligoMetastatic Breast CancerRecruitingNCT05377047Phase 3
• An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain MetastasisRecruitingNCT05376878Phase 4
• An Intervention for Female Breast CANcer: Acceptance and Commitment Therapy (I-CAN-ACT) for Depression and Physical PainRecruitingNCT05374161Not applicable
• Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid TumorsRecruitingNCT05372640Phase 1
• Identifying Prognostic Variables for Persistent UL Dysfunctions After Breast Cancer Treatment -Reliability and ValidityRecruitingNCT05371847Not applicable
• SNAPS Breast Cancer Patient Study Breast Cancer PatientsNot yet recruitingNCT05370300
• Lesion Composition and Quantitative Imaging Analysis on Breast Cancer DiagnosisRecruitingNCT05369546
• cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseRecruitingNCT05366881
• Optimizing Postoperative Recovery After Breast Reconstruction With Autologous Tissue (BestDIEP)RecruitingNCT05363189
• Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect ManagementRecruitingNCT05362760Phase 4
• CTCs in Breast Cancer After Neoadjuvant Treatment and Surgery: a Multicenter, Prospective Clinical TrialRecruitingNCT05360290Not applicable
• AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad OncRecruitingNCT05351424Not applicable

← Breast Neoplasms overview